The Ayurveda and Unani Licensing Authority in Uttarakhand on Wednesday directed Ramdev’s Patanjali Ayurved to stop manufacturing five products citing misleading advertisements.
The products are Madhugrit, Eyegrit, Thyrogrit, BPgrit and Lipidom.
The five products were promoted by the company as a treatment for blood pressure, diabetes, goitre, glaucoma and high cholesterol, The Telegraph reported.
The order was passed in response to a complaint by a Kerala-based ophthalmologist named KV Babu.
Babu, in his complaint, had claimed that the advertisements violated the Drugs and Cosmetics Act and the Magic Remedies Act. The laws prohibit advertisements that promote the treatment of certain diseases and conditions, including blood pressure, glaucoma, goitre and diabetes, according to Scroll.in.
“We have constituted a team that will review the formulation sheet of these drugs once the authorities at Divya Pharmacy submit the same to us,” The Hindu quoted GCS Jangpangi, licence officer at the authority, as saying. “They have also been asked to submit a revised label claim to the department within a week.”